Haematuria in Critically Ill Cancer Patients

Sridhar Panaiyadiyan; Prabhjot Singh; Brusabhanu Nayak

doi:10.1007/978-981-16-9929-0_27

Haematuria in Critically Ill Cancer Patients

Sridhar Panaiyadiyan
, Prabhjot Singh
, Brusabhanu Nayak

Department of Urology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Haematuria is an emergent condition which is dramatic to patients due to its gross appearance and daunting to physicians because of various underlying causes. Various classifications exist to stratify haematuria based on severity, site of origin, time and duration of bleed. Although an underlying malignancy is always suspected, however, it is often caused by common conditions such as infections, inflammatory conditions, urolithiasis and various other benign conditions. There is a lack of clear consensus in the management of haematuria, particularly in critically ill patients. This chapter reviews the aetiopathogenesis, clinical presentations, and management of haematuria in critically ill cancer patients.

Original language	English (US)
Title of host publication	Onco-critical Care
Subtitle of host publication	An Evidence-based Approach
Publisher	Springer Nature
Pages	301-314
Number of pages	14
ISBN (Electronic)	9789811699290
ISBN (Print)	9789811699283
DOIs	https://doi.org/10.1007/978-981-16-9929-0_27
State	Published - Jan 1 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine
General Nursing

Access to Document

10.1007/978-981-16-9929-0_27

Cite this

@inbook{cd607768445f4a2da5eb5fa95f850d26,

title = "Haematuria in Critically Ill Cancer Patients",

abstract = "Haematuria is an emergent condition which is dramatic to patients due to its gross appearance and daunting to physicians because of various underlying causes. Various classifications exist to stratify haematuria based on severity, site of origin, time and duration of bleed. Although an underlying malignancy is always suspected, however, it is often caused by common conditions such as infections, inflammatory conditions, urolithiasis and various other benign conditions. There is a lack of clear consensus in the management of haematuria, particularly in critically ill patients. This chapter reviews the aetiopathogenesis, clinical presentations, and management of haematuria in critically ill cancer patients.",

author = "Sridhar Panaiyadiyan and Prabhjot Singh and Brusabhanu Nayak",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-981-16-9929-0\_27",

language = "English (US)",

isbn = "9789811699283",

pages = "301--314",

booktitle = "Onco-critical Care",

publisher = "Springer Nature",

address = "United States",

}

TY - CHAP

T1 - Haematuria in Critically Ill Cancer Patients

AU - Panaiyadiyan, Sridhar

AU - Singh, Prabhjot

AU - Nayak, Brusabhanu

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Haematuria is an emergent condition which is dramatic to patients due to its gross appearance and daunting to physicians because of various underlying causes. Various classifications exist to stratify haematuria based on severity, site of origin, time and duration of bleed. Although an underlying malignancy is always suspected, however, it is often caused by common conditions such as infections, inflammatory conditions, urolithiasis and various other benign conditions. There is a lack of clear consensus in the management of haematuria, particularly in critically ill patients. This chapter reviews the aetiopathogenesis, clinical presentations, and management of haematuria in critically ill cancer patients.

AB - Haematuria is an emergent condition which is dramatic to patients due to its gross appearance and daunting to physicians because of various underlying causes. Various classifications exist to stratify haematuria based on severity, site of origin, time and duration of bleed. Although an underlying malignancy is always suspected, however, it is often caused by common conditions such as infections, inflammatory conditions, urolithiasis and various other benign conditions. There is a lack of clear consensus in the management of haematuria, particularly in critically ill patients. This chapter reviews the aetiopathogenesis, clinical presentations, and management of haematuria in critically ill cancer patients.

UR - https://www.scopus.com/pages/publications/85163478192

UR - https://www.scopus.com/pages/publications/85163478192#tab=citedBy

U2 - 10.1007/978-981-16-9929-0_27

DO - 10.1007/978-981-16-9929-0_27

M3 - Chapter

AN - SCOPUS:85163478192

SN - 9789811699283

SP - 301

EP - 314

BT - Onco-critical Care

PB - Springer Nature

ER -

Haematuria in Critically Ill Cancer Patients

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this